SCHEDULE: Deep Track Capital Discloses 5.51% Stake in Personalis

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have jointly filed a Schedule 13G, reporting beneficial ownership of 5,760,627 shares, representing 5.51% of Personalis, Inc.'s common stock.

Summary

• Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have collectively acquired beneficial ownership of 5,760,627 shares of Personalis, Inc. common stock.
• This holding represents 5.51% of the total outstanding shares of Personalis, Inc.
• The filing is made under Schedule 13G, indicating that the ownership is not for the purpose of changing or influencing the control of the issuer.
• The total number of outstanding shares used for this calculation is 104,631,832, as reported by Personalis, Inc. on February 20, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing, as it indicates a significant passive investment by an institutional entity, suggesting belief in the company's underlying value, but without direct company performance updates.

Positives

• Significant stake acquired by Deep Track Capital, indicating confidence in Personalis, Inc.'s future prospects.
• The filing is a Schedule 13G, suggesting a passive investment rather than a hostile takeover attempt, which is generally viewed positively by the market.

Risks

• The filing does not detail specific risks, but any investment in a publicly traded company carries inherent market risks.
• Concentration of ownership by a single entity could potentially lead to increased volatility if that entity decides to divest its holdings.

Future Outlook

The filing does not contain forward-looking statements or guidance from the company itself. The future outlook is based on the investment actions of Deep Track Capital.

Industry Context

StockSavvy.ai notes that significant institutional investment, as indicated by this Schedule 13G filing, can signal growing investor confidence in the precision medicine and diagnostics sector, where Personalis, Inc. operates. This filing suggests a notable position taken by Deep Track Capital within this competitive landscape.

Stakeholder Impact

• Shareholders: May view the increased institutional ownership positively, potentially leading to increased liquidity and market interest.
• Management: May interpret this as a vote of confidence, but also a signal to maintain performance and governance standards.
• Competitors: May note the significant stake taken by an investment firm in the sector.

Next Steps

• Monitor future filings from Deep Track Capital for any changes in their stake.
• Observe Personalis, Inc.'s subsequent financial reports and strategic announcements for performance indicators.

Key Dates

Recommendation

The filing indicates a significant passive investment by Deep Track Capital, suggesting a belief in Personalis, Inc.'s long-term value. However, without direct company performance updates or forward-looking guidance, a 'hold' recommendation is prudent, allowing for further assessment of the company's operational and financial trajectory.

Keywords

Personalis, Inc., Schedule 13G, Deep Track Capital, Beneficial Ownership, Common Stock, SEC Filing, Investment, Biotechnology